HHS Temporarily Allows Six Peptides to Be Compounded — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- HHS issued a policy authorizing the temporary compounding of six experimental peptides.
- BPC-157 is among the six peptides covered and, with TB-500, forms what the article describes as a popular injury-recovery duo.
- HHS allows licensed pharmacies and physicians to temporarily compound the six covered peptides without fear of federal enforcement.
- FDA career scientists objected to the policy, saying there is scant evidence that the substances are safe or effective.
Why it matters: Licensed pharmacies and physicians gain a six-peptide enforcement shield through HHS’s policy, while FDA career scientists say there is scant evidence that the compounds are safe or effective. The material change is temporary compounding without federal-enforcement exposure; the objections over safety and efficacy remain unresolved.
Ask SkimNews
